_version_ 1785090898412961792
author Torra, Silvia Marce
Méndez, Aleix
Sturla, Antonella Luciana
Ratia, Miriam
Figueras, Anna Angona
Amat, Paula
Ferrer-Marín, Francisca
Escribano, Silvia
Scalzulli, Emilia
Sansa, Montserrat Cortes
Plensa, Esther
Estrada, Natalia
Marco, Marta Cabezon
Morgades, Mireia
Magan, Maria Alicia Senin
Hernandez-Boluda, Juan Carlos
Anguita, Eduardo
Breccia, Massimo
García-Gutiérrez, Valentín
Cirici, Blanca Xicoy
Zamora, Lurdes
author_facet Torra, Silvia Marce
Méndez, Aleix
Sturla, Antonella Luciana
Ratia, Miriam
Figueras, Anna Angona
Amat, Paula
Ferrer-Marín, Francisca
Escribano, Silvia
Scalzulli, Emilia
Sansa, Montserrat Cortes
Plensa, Esther
Estrada, Natalia
Marco, Marta Cabezon
Morgades, Mireia
Magan, Maria Alicia Senin
Hernandez-Boluda, Juan Carlos
Anguita, Eduardo
Breccia, Massimo
García-Gutiérrez, Valentín
Cirici, Blanca Xicoy
Zamora, Lurdes
author_sort Torra, Silvia Marce
collection PubMed
description
format Online
Article
Text
id pubmed-10430186
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104301862023-08-17 PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI Torra, Silvia Marce Méndez, Aleix Sturla, Antonella Luciana Ratia, Miriam Figueras, Anna Angona Amat, Paula Ferrer-Marín, Francisca Escribano, Silvia Scalzulli, Emilia Sansa, Montserrat Cortes Plensa, Esther Estrada, Natalia Marco, Marta Cabezon Morgades, Mireia Magan, Maria Alicia Senin Hernandez-Boluda, Juan Carlos Anguita, Eduardo Breccia, Massimo García-Gutiérrez, Valentín Cirici, Blanca Xicoy Zamora, Lurdes Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430186/ http://dx.doi.org/10.1097/01.HS9.0000974664.15321.9d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Torra, Silvia Marce
Méndez, Aleix
Sturla, Antonella Luciana
Ratia, Miriam
Figueras, Anna Angona
Amat, Paula
Ferrer-Marín, Francisca
Escribano, Silvia
Scalzulli, Emilia
Sansa, Montserrat Cortes
Plensa, Esther
Estrada, Natalia
Marco, Marta Cabezon
Morgades, Mireia
Magan, Maria Alicia Senin
Hernandez-Boluda, Juan Carlos
Anguita, Eduardo
Breccia, Massimo
García-Gutiérrez, Valentín
Cirici, Blanca Xicoy
Zamora, Lurdes
PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_full PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_fullStr PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_full_unstemmed PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_short PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_sort pb1962: influence of transcript types in sustained deep molecular response (sdmr) and treatment-free remission (tfr) in chronic phase-chronic myeloid leukemia (cp-cml) patients treated with tki
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430186/
http://dx.doi.org/10.1097/01.HS9.0000974664.15321.9d
work_keys_str_mv AT torrasilviamarce pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT mendezaleix pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT sturlaantonellaluciana pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT ratiamiriam pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT figuerasannaangona pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT amatpaula pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT ferrermarinfrancisca pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT escribanosilvia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT scalzulliemilia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT sansamontserratcortes pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT plensaesther pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT estradanatalia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT marcomartacabezon pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT morgadesmireia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT maganmariaaliciasenin pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT hernandezboludajuancarlos pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT anguitaeduardo pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT brecciamassimo pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT garciagutierrezvalentin pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT ciriciblancaxicoy pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT zamoralurdes pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki